Louisiana Wholesale Drug Co. v. Bayer AG
Petition for certiorari denied on March 7, 2011| Docket No. | Op. Below | Argument | Opinion | Vote | Author | Term |
|---|---|---|---|---|---|---|
| 10-762 | 2d Cir. | N/A | N/A | N/A | N/A | OT 2010 |
Issue: Whether, absent patent fraud or sham litigation, a brand drug maker's substantial payment to a competing generic drug maker to forgo judicial testing of the patent and restrict entry is per se lawful under the Sherman Act.
Briefs and Documents
Certiorari-stage documents
- Opinion below (2d Cir.)
- Petition for certiorari
- Brief in opposition of Barr Laboratories et al.
- Brief in opposition of Bayer AG et al.
- Petitioners' reply
- Amicus brief of the American Antitrust Institute
- Amicus brief of California et al.
- Amicus brief of 86 Professors
- Amicus brief of the Consumer Federation of America et al.
- Amicus brief of AARP
- Amicus brief of the Public Patent Foundation
- Amicus brief of the National Association of Chain Drug Stores, Inc.
Submit Event
